Stock Analysis on Net

Boston Scientific Corp. (NYSE:BSX)

$22.49

This company has been moved to the archive! The financial data has not been updated since May 4, 2023.

Price to Book Value (P/BV)
since 2005

Microsoft Excel

Paying user area

The data is hidden behind: . Unhide it.

This is a one-time payment. There is no automatic renewal.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Calculation

Boston Scientific Corp., P/BV, long-term trends, calculation

Microsoft Excel

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).

1 US$

2 Data adjusted for splits and stock dividends.

3 Closing price as at the filing date of Boston Scientific Corp. Annual Report.


Share Price Trend
The share price experienced a notable decline from $24 in 2006 to a low point of $6.09 in 2012, indicating a prolonged period of depreciation. From 2013 onwards, the share price showed a consistent upward trend, rising significantly to reach $47.18 by 2023. This recovery and growth phase reflects increased market valuation and investor confidence over the last decade.
Book Value Per Share (BVPS) Trend
Book value per share initially rose sharply from $5.21 in 2006 to a peak of $10.33 in 2007, before gradually declining to $4.69 in 2016. Since 2017, BVPS has demonstrated steady growth, climbing to $12.25 by 2023. The early volatility followed by sustained increase suggests improvements in the company’s net asset base or equity over recent years.
Price-to-Book Value (P/BV) Ratio Trend
The P/BV ratio showed a strong contraction from 4.6 in 2006 down to a trough of 0.78 in 2012, reflecting the period when share price was underperforming relative to book value. As the share price recovered from 2013 onwards, the P/BV ratio escalated sharply, peaking at 6.33 in 2019. Subsequently, it moderated somewhat but remained elevated above 3.5 through 2023, indicating that the market continued to price the shares at a premium over book value.
Overall Insights
The data reveals an early period (2006-2012) characterized by declining share price and P/BV ratio, despite relatively stable or fluctuating book value. This may indicate challenges faced by the company impacting investor sentiment. From 2013 onwards, both the share price and BVPS increased, with the share price appreciating more rapidly, resulting in a rising P/BV ratio and signaling improved market optimism and potentially enhanced financial performance or growth prospects.

Comparison to Competitors

Boston Scientific Corp., P/BV, long-term trends, comparison to competitors

Microsoft Excel

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).


Comparison to Sector (Health Care Equipment & Services)

Boston Scientific Corp., P/BV, long-term trends, comparison to sector (health care equipment & services)

Microsoft Excel

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).


Comparison to Industry (Health Care)